Wearable ECG Clipping Detection With Dynamic Gain Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Wearable medical devices, such as defibrillators, face signal distortion due to analog and digital signal clipping, which can lead to false arrhythmia detection and unnecessary shocks or failure to detect arrhythmias, compromising patient safety.
Innovation Solution
A wearable medical device with a programmable attenuation/gain stage and an analog-to-digital converter, coupled with a signal conditioning and control unit that detects clipping by monitoring digitized ECG signals and adjusts attenuation to prevent clipping, ensuring reliable signal processing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of energy
If multiple amplifier stages are used to maximize signal-to-noise ratio, then noise reduction is improved, but signal clipping susceptibility increases
Solution Approach 1:
The patent implements a feedback mechanism where the processor monitors the digitized ECG signal for clipping indicators and dynamically adjusts the attenuation setting of the programmable attenuation stage. This closed-loop feedback system allows the device to maintain optimal signal-to-noise ratio while preventing signal clipping by adapting the attenuation level based on real-time signal conditions.
Solution Approach 2:
The patent employs dynamic adjustment of the programmable attenuation stage based on monitored signal characteristics. The system transitions from static attenuation settings to dynamic control, where the attenuation level is continuously adapted based on the detected ECG signal amplitude and clipping indicators, allowing optimal performance across varying signal conditions.
2Measurement precision
If amplification gain is increased to maximize ECG signal amplitude, then signal detection capability is improved, but analog clipping occurs
Solution Approach 1:
The patent applies preliminary attenuation before the signal enters the multiple amplifier stages. By pre-attenuating the ECG signal at the programmable attenuation stage before amplification, the system prevents the signal from exceeding the maximum input level of subsequent amplifier stages, thereby avoiding analog clipping while still allowing sufficient signal amplitude for accurate detection.
Solution Approach 2:
The programmable attenuation stage serves as an intermediary element between the ECG electrodes and the amplifier stages. This intermediate stage controls the signal level entering the amplification chain, acting as a buffer that prevents signal overload while maintaining detection sensitivity through dynamic adjustment capabilities.
3Reliability
If programmable attenuation stage is added to control signal levels, then clipping prevention is improved, but device complexity increases
Solution Approach 1:
The processor in the wearable medical device performs multiple functions including ECG signal analysis, clipping detection, and dynamic control of the programmable attenuation stage. By integrating these functions into a single processing unit, the patent avoids adding separate dedicated circuits for each function, thereby minimizing the increase in device complexity while achieving reliable clipping prevention.
4Measurement precision
If dynamic attenuation adjustment is implemented to prevent clipping, then signal quality is improved, but processing complexity increases
Solution Approach 1:
The system performs self-adjustment by automatically detecting clipping indicators in the digitized ECG signal and autonomously modifying the attenuation setting of the programmable attenuation stage. This self-service mechanism eliminates the need for external manual adjustment or complex external control systems, allowing dynamic optimization of signal quality through relatively simple integrated processing.
Data Source
AI summary
A wearable medical device and method of detecting clipping of ECG signals is disclosed. In one embodiment, the wearable medical device comprises a plurality of ECG sensing electrodes configured to sense an ECG of a patient and an ECG acquisition circuit electrically coupled to a pair of the plurality of ECG sensing electrodes and configured to provide an amplified and conditioned analog ECG signal, a programmable attenuation/gain stage electrically coupled between a first gain stage and a second gain stage, an ADC electrically coupled to the ECG acquisition circuit to receive and digitize the amplified and conditioned analog ECG signal and provide a digitized ECG signal, and a signal conditioning and control unit electrically coupled to the ECG acquisition circuit and the ADC to receive and monitor the digitized ECG signal and to detect clipping of the amplified and conditioned analog ECG signal based upon the digitized ECG signal.